Filter Results
Related Organization
- Biological and Environmental Systems Science Directorate (26)
- Computing and Computational Sciences Directorate (38)
- Energy Science and Technology Directorate (223)
- Fusion and Fission Energy and Science Directorate (24)
- Information Technology Services Directorate (3)
- Isotope Science and Enrichment Directorate (7)
- National Security Sciences Directorate (20)
- Neutron Sciences Directorate (11)
- Physical Sciences Directorate (135)
- User Facilities (27)
Researcher
- Benjamin Manard
- Cyril Thompson
- Alexander I Wiechert
- Annetta Burger
- Bruce Moyer
- Carter Christopher
- Chance C Brown
- Charles F Weber
- Costas Tsouris
- Debjani Pal
- Debraj De
- Gautam Malviya Thakur
- James Gaboardi
- Jeffrey Einkauf
- Jennifer M Pyles
- Jesse McGaha
- Joanna Mcfarlane
- Jonathan Willocks
- Justin Griswold
- Kevin Sparks
- Kuntal De
- Laetitia H Delmau
- Liz McBride
- Luke Sadergaski
- Matt Vick
- Mike Zach
- Padhraic L Mulligan
- Sandra Davern
- Todd Thomas
- Vandana Rallabandi
- Xiuling Nie

Often there are major challenges in developing diverse and complex human mobility metrics systematically and quickly.

High-gradient magnetic filtration (HGMF) is a non-destructive separation technique that captures magnetic constituents from a matrix containing other non-magnetic species. One characteristic that actinide metals share across much of the group is that they are magnetic.

Ruthenium is recovered from used nuclear fuel in an oxidizing environment by depositing the volatile RuO4 species onto a polymeric substrate.

Spherical powders applied to nuclear targetry for isotope production will allow for enhanced heat transfer properties, tailored thermal conductivity and minimize time required for target fabrication and post processing.

Biocompatible nanoparticles have been developed that can trap and retain therapeutic radionuclides and their byproducts at the cancer site. This is important to maximize the therapeutic effect of this treatment and minimize associated side effects.

An ORNL team has developed a method for screening for an immunoregulatory protein, which includes assessing the sequence of a candidate protein to determine if it is an immunoregulatory protein when at least one plasminogen-apple-nematode (PAN) domain with a consensus sequence